Community pharmacies struggling to buy Part VIII medicines at or below the published Drug Tariff price now have a direct route to flag the problem. Community Pharmacy England (CPE) is asking contractors to submit reporting forms detailing suppliers, prices paid, and stock availability whenever a product cannot be sourced within the Tariff limit. The data collected underpins any decision to apply for a price concession from the Department of Health and Social Care (DHSC).
Why Price Reporting Matters
Part VIII of the Drug Tariff sets the reimbursement price the NHS pays pharmacies for a defined list of medicines. When wholesale or manufacturer prices rise above that reimbursement figure, pharmacies can end up dispensing at a loss unless DHSC grants a temporary price concession. These concessions are not automatic. They depend on evidence that a genuine, widespread sourcing problem exists, rather than an isolated or temporary blip affecting a single pharmacy or wholesaler.
This is where contractor reporting becomes essential. CPE does not set concession prices itself; it collates evidence from pharmacies nationwide and uses that evidence to build a case to DHSC. Without a critical mass of consistent reports, naming suppliers, prices paid, and the scale of disruption, an application is unlikely to succeed. The system relies on pharmacies actively documenting their experience rather than assuming someone else will do it.
What Information Actually Helps
The reporting form is designed to capture specifics that strengthen an application rather than general complaints. Useful detail includes which wholesaler was contacted, what price was ultimately paid, whether a different manufacturer's version of the product was substituted, and what impact the shortage had on patient care or dispensing timelines.
- Supplier name and the price actually paid above Tariff
- Manufacturer or brand variation, if the product received differed from the one ordered
- Scale of the issue - single occurrence or a pattern across multiple attempts
- Operational impact, such as delayed dispensing or the need to source from multiple wholesalers
For pharmacies encountering shortfalls across several products, a bulk-reporting spreadsheet is available and can be emailed directly to CPE's concessions team, reducing the administrative burden compared with submitting separate forms for each item.
The Bigger Picture for Pharmacy Finances
Price concessions sit at the intersection of clinical supply and pharmacy business viability. Medicine shortages, manufacturing disruptions, and global supply chain pressures can push wholesale prices above Tariff rates with little warning, and pharmacies are contractually obliged to dispense regardless of the margin outcome. A transparent, evidence-based concession process protects contractors from absorbing losses caused by market conditions outside their control, while also giving DHSC a mechanism to intervene only where the problem is demonstrably widespread rather than anecdotal.
This reporting mechanism reflects a broader principle in regulated supply markets: oversight bodies act on verified patterns of disruption, not isolated incidents. For pharmacy contractors, consistent and detailed reporting is not an administrative formality - it is the evidentiary foundation that determines whether financial relief materializes at all.